Vaccination Recommendations for Adults Flashcards
influenza vaccine type
- inactivated
- live attenuated
- recombinant
influenza ACIP recommendation
- annual for anyone ≥ 6 months of age
tetanus, diphtheria, pertussis vaccine type
- inactivated
tetanus, diphtheria, pertussis ACIP recommendation for adults
- primary series for unvaccinated adults
- Td booster every 10 years for all adults
- one-time pertussis booster w/ Tdap for all adults
tetanus, diphtheria, pertussis ACIP recommendation for pregnant women
- all pregnant women 27-36 weeks gestation during EACH pregnancy
varicella vaccine type
- live attenuated
varicella ACIP recommendation
- 2 doses ≥ 4 weeks apart for anyone w/o VZV immunity
herpes zoster vaccine type
- inactivated
- live attenuated
herpes zoster ACIP recommendation
- inactivated –> anyone ≥ 50 yoa
- live attenuated –> all immunocompromised pts ≥ 60 yoa
pneumococcal vaccine type
- inactivated
pneumococcal ACIP recommendation
- all adults ≥ 65 yoa
- 19-64 yoa WITH risk factors
if pt ≥ 65 yoa NEVER received pneumococcal vaccine, wtd?
- PCV13 (conjugate) once
- then PPSV23 (polysaccharide) at least 1 year after
if received PPSV23 at or after 65 yoa, wtd?
- PCV13 once at least 1 year after last PPSV23 vaccine given
if received PPSV23 before 65 yoa, wtd?
- PCV13 once at least 1 year after last PPSV23 vaccine given
- then another PPSV23 at least 1 year after
human papillomavirus vaccine type
- inactivated
human papillomavirus ACIP recommendation for females
- vaccinate from 11 to 26 yoa
human papillomavirus ACIP recommendation for males
- vaccinate from 11 to 26 yoa
human papillomavirus ACIP recommendation for immunocompromised pts (including HIV pts) and MSM persons
- vaccinate up to 26 yoa
measles, mumps, rubella vaccine type
- live attenuated
measles, mumps, rubella ACIP recommendation
- if born in 1957 or later w/o evidence of vaccination or immunity
- one dose usually suficient
measles, mumps, rubella ACIP recommendation for 2nd dose
- college students
- international travelers
- HCWs
measles, mumps, rubella ACIP recommendation for 3rd dose
- pts at increased risk during outbreak
meningococcal serogroups A, C, W135, and Y vaccine type
- inactivated
meningococcal serogroups A, C, W135, and Y ACIP recommendation for 1 dose
- 1st year college students in dorms (unless already vaccinated at ≥ 16 yoa, travelers to endemic areas, microbiologists exposed to N. meningitidis, military recruits, exposed persons
meningococcal serogroups A, C, W135, and Y ACIP recommendation for 2 doses
- pts w/ asplenia or complements deficiencies
- HIV pts
meningococcal serogroups A, C, W135, and Y ACIP recommendation for revaccination
- every 5 years if persistent risk
meningococcal serogroup B vaccine type
- inactivated
meningococcal serogroup B ACIP recommendation for 2 doses
- anatomic/functional asplenia
- persistent complement deficiencies
- eculizumab use
- microbiologists exposed to N. meningitidis
- increased risk during outbreak
hepatitis A vaccine type
- inactivated
hepatitis A ACIP recommendation
- any adult requesting immunization
- if high risk
hepatitis A vaccine type
- inactivated
hepatitis B ACIP recommendation
- any adult requesting immunization
- if high risk
contraindications to live vaccines
- pregnancy
- HIV or AIDS w/ CD4 cell count ≤ 200/µL or ≤ 15% of total lymphocytes
- immunosuppressant therapy, including high-dose glucocorticoids (≥ 20 mg/d of prednisone or equivalent)
- leukemia, lymphoma, or other bone marrow and lymphatic system malignancies
- cellular immunodeficiency
- solid-organ transplant recipient
- current hematopoietic stem cell transplantation